181 related articles for article (PubMed ID: 32192517)
41. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
[TBL] [Abstract][Full Text] [Related]
42. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
43. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
Wang Y; Zhao Q; Lan N; Wang S
Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
[TBL] [Abstract][Full Text] [Related]
44. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
45. High Expression of
Deng H; Huang Y; Wang L; Chen M
Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
[TBL] [Abstract][Full Text] [Related]
47. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
[TBL] [Abstract][Full Text] [Related]
48. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
49. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive analyses of DNA methylation and gene expression profiles of Kawasaki disease.
Chang D; Qian C; Li H; Feng H
J Cell Biochem; 2019 Aug; 120(8):13001-13011. PubMed ID: 30861201
[TBL] [Abstract][Full Text] [Related]
51. Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome.
Liu L; He D; Wang Y; Sheng M
Mol Med Rep; 2020 May; 21(5):2138-2150. PubMed ID: 32323770
[TBL] [Abstract][Full Text] [Related]
52. Identification of abnormally methylated-differentially expressed genes and pathways in osteoarthritis: a comprehensive bioinformatic study.
Zheng L; Chen W; Xian G; Pan B; Ye Y; Gu M; Ma Y; Zhang Z; Sheng P
Clin Rheumatol; 2021 Aug; 40(8):3247-3256. PubMed ID: 33420869
[TBL] [Abstract][Full Text] [Related]
53. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
54. Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes.
Shen J; Zhu B
Mol Med Rep; 2018 Jun; 17(6):7636-7644. PubMed ID: 29620215
[TBL] [Abstract][Full Text] [Related]
55. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract][Full Text] [Related]
56. Four genes relevant to pathological grade and prognosis in ovarian cancer.
Pan X; Chen Y; Gao S
Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
[TBL] [Abstract][Full Text] [Related]
57. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
58. Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
Liu J; Wan Y; Li S; Qiu H; Jiang Y; Ma X; Zhou S; Cheng W
Cancer Med; 2020 May; 9(10):3522-3536. PubMed ID: 32170852
[TBL] [Abstract][Full Text] [Related]
59. Identification of Key Differentially Methylated/Expressed Genes and Pathways for Ovarian Endometriosis by Bioinformatics Analysis.
Zhang H; Wu J; Li Y; Jin G; Tian Y; Kang S
Reprod Sci; 2022 May; 29(5):1630-1643. PubMed ID: 34671938
[TBL] [Abstract][Full Text] [Related]
60. Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.
Gui T; Yao C; Jia B; Shen K
PLoS One; 2021; 16(6):e0253136. PubMed ID: 34143800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
